This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Regadenoson
400 mcg/5 ml, Roztwór do wstrzykiwań
INN: Regadenosonum
Data updated: 2026-04-13
Available in:
🇨🇿🇩🇪🇬🇧🇪🇸🇵🇱🇸🇰
Form
Roztwór do wstrzykiwań
Dosage
400 mcg/5 ml
Route
dożylna
Storage
Store at controlled room temperature, 25°C (77°F); excursions permitted to 15° to 30°C (59°– 86°F).
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
GE Healthcare AS (Norwegia)
Composition
Regadenosonum 400 mcg
ATC Code
C01EB21
Source
URPL
11 DESCRIPTION Regadenoson is an A 2A adenosine receptor agonist that is a coronary vasodilator [see Clinical Pharmacology ( 12.1 ) ]. Regadenoson is chemically described as adenosine, 2-[4-[(methylamino)carbonyl]-1 H -pyrazol-1-yl].Its structural formula is: The molecular formula for regadenoson is C 15 H 18 N 8 O 5 and its molecular weight is 390.35. Regadenoson is a sterile, nonpyrogenic solution for intravenous injection. The solution is clear and colorless. Each 1 mL in the 5 mL pre-filled syringe contains 0.08 mg regadenoson on an anhydrous basis, 10.9 mg dibasic sodium phosphate dihydrate, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate, and Water for Injection, with pH between 6.3 and 7.7.
⚠️ Warnings
• Caution should be exercised in patients with history of heart disease or high blood pressure, asthma or COPD (chronic obstructive pulmonary disease), kidney or liver impairment, vomiting or diarrhea, any allergy, during pregnancy and breastfeeding.
• It may cause dizziness, do not drive a car or operate machinery while taking this medication.